Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Structural dynamics of HIV-1 envelope Gp120 outer domain with V3 loop.

Yokoyama M, Naganawa S, Yoshimura K, Matsushita S, Sato H.

PLoS One. 2012;7(5):e37530. doi: 10.1371/journal.pone.0037530. Epub 2012 May 18.

2.

V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.

Laakso MM, Lee FH, Haggarty B, Agrawal C, Nolan KM, Biscone M, Romano J, Jordan AP, Leslie GJ, Meissner EG, Su L, Hoxie JA, Doms RW.

PLoS Pathog. 2007 Aug 24;3(8):e117.

3.
4.

Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.

Borbe HC, Stuber G, Wagner R, Wolf H, Modrow S.

J Pept Sci. 1995 Mar-Apr;1(2):109-23.

PMID:
9222988
5.

Net positive charge of HIV-1 CRF01_AE V3 sequence regulates viral sensitivity to humoral immunity.

Naganawa S, Yokoyama M, Shiino T, Suzuki T, Ishigatsubo Y, Ueda A, Shirai A, Takeno M, Hayakawa S, Sato S, Tochikubo O, Kiyoura S, Sawada K, Ikegami T, Kanda T, Kitamura K, Sato H.

PLoS One. 2008 Sep 12;3(9):e3206. doi: 10.1371/journal.pone.0003206.

7.

NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding.

Tugarinov V, Zvi A, Levy R, Hayek Y, Matsushita S, Anglister J.

Structure. 2000 Apr 15;8(4):385-95.

8.
9.

Structural dynamics of V3 loop with different electrostatics: implications on co-receptor recognition: a molecular dynamics study of HIV gp120.

Chandramouli B, Chillemi G, Giombini E, Capobianchi MR, Rozera G, Desideri A.

J Biomol Struct Dyn. 2013 Apr;31(4):403-13. doi: 10.1080/07391102.2012.703068. Epub 2012 Aug 9.

PMID:
22876913
10.

Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.

Chakraborty K, Durani V, Miranda ER, Citron M, Liang X, Schleif W, Joyce JG, Varadarajan R.

Biochem J. 2006 Nov 1;399(3):483-91.

11.

Structure and dynamics of the gp120 V3 loop that confers noncompetitive resistance in R5 HIV-1(JR-FL) to maraviroc.

Yuan Y, Yokoyama M, Maeda Y, Terasawa H, Harada S, Sato H, Yusa K.

PLoS One. 2013 Jun 28;8(6):e65115. doi: 10.1371/journal.pone.0065115. Print 2013.

13.

Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4.

Gram GJ, Hemming A, Bolmstedt A, Jansson B, Olofsson S, Akerblom L, Nielsen JO, Hansen JE.

Arch Virol. 1994;139(3-4):253-61.

PMID:
7832633
15.

Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.

Rosen O, Chill J, Sharon M, Kessler N, Mester B, Zolla-Pazner S, Anglister J.

Biochemistry. 2005 May 17;44(19):7250-8.

PMID:
15882063
16.

Importance of V3 loop flexibility and net charge in the context of co-receptor recognition. A molecular dynamics study on HIV gp120.

Chandramouli B, Chillemi G, Abbate I, Capobianchi MR, Rozera G, Desideri A.

J Biomol Struct Dyn. 2012;29(5):879-91.

PMID:
22292949
17.

The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.

Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T.

Virology. 1998 Nov 10;251(1):59-70.

18.

Structural analysis of the envelope gp120 V3 loop for some HIV-1 variants circulating in the countries of Eastern Europe.

Andrianov AM, Kornoushenko YV, Anishchenko IV, Eremin VF, Tuzikov AV.

J Biomol Struct Dyn. 2013;31(7):665-83. doi: 10.1080/07391102.2012.706455. Epub 2012 Aug 13.

PMID:
22888999
19.

Mechanism of anti-HIV activity of succinylated human serum albumin.

Kuipers ME, vd Berg M, Swart PJ, Laman JD, Meijer DK, Koppelman MH, Huisman H.

Biochem Pharmacol. 1999 Apr 15;57(8):889-98.

PMID:
10086322
20.

Supplemental Content

Support Center